Latest filing published 03 May 2013 for UNIGENE LABORATORIES INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Theron Edwin Odlaug has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Unigene Laboratories Inc and Advanced Life Sciences Holdings, Inc. In total, 9 filings cover trades dated from 13 August 2007 to 1 May 2013.
No open-market sale appears; the market trades are 4 purchases worth €16k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants.
A typical purchase (the median) is worth €4,197.
Most recently, on 3 May 2013, the filings show a share grant in Unigene Laboratories Inc. The last purchase on record was published on 22 December 2011, which is 5,419 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations